January 2, 2025 By Dwight Akerman, OD, MBA, FAAO, Dipl AAO, FBCLA, FIACLE Juvenile-onset myopia has gained the scientific community’s attention, and...
January 2, 2025 By Leila Sara Eppenberger, MD, FEBO, FMH, MSc ETH Over the past few decades, the options for controlling myopia...
November 15, 2024 By Dwight Akerman, OD, MBA, FAAO, FBCLA, FIACLE In the article “Putting efficacy into context: do controlled trials on...
November 1, 2024 Dwight Akerman, OD, MBA, FAAO, FBCLA, FIACLE In their review article, “Efficacy in myopia control — The impact of...
October 10, 2024 Researchers in the field of myopia management from across the globe gathered in Hainan Island, China, for the International...
October 7, 2024 HAINAN ISLAND, China — At the 19th International Myopia Conference, HOYA Vision Care shared the eight-year results from its...
October 1, 2024 By Diba Rezazadeh, OD, AdvCertChVis(ACO) Topical low-dose atropine has become a popular myopia control treatment, and its ability to...
October 1, 2024 By Dwight Akerman, OD, MBA, FAAO, FBCLA, FIACLE The retrospective study conducted by Wen et al. (2024) aimed to...
September 16, 2024 By Dwight Akerman, OD, MBA, FAAO, FBCLA, FIACLE The paper “A New Look at the Myopia Control Efficacy of...
September 16, 2024 By Dwight Akerman, OD, MBA, FAAO, FBCLA, FIACLE In their article “Can we really distinguish ‘responders’ from ‘non-responders’ to...
sponsored content August 15, 2024 When it comes to choosing a myopia management treatment modality, there are several factors to consider beyond...
August 1, 2024 By Catherine Tay, BOptom, GradCertPublicHealth Environmental factors, genetic factors, and patient characteristics are important determinants that may help guide...
July 1, 2024 By Dwight Akerman, OD, MBA, FAAO, FBCLA, FIACLE The article “Effectiveness of Orthokeratology and Myopia Control Spectacles in a...
June 3, 2024 By Eman Ali Alzghoul, PhD candidate at the School of Optometry and Vision Science, University of New South Wales...
May 28, 2024 BERLIN, Germany — Dopavision has announced early findings from its clinical trial for MyopiaX-1. The six-month outcomes of the...
May 1, 2024 By Hashim Ali Khan, OD, FAAO, Dipl AAO, PhD Candidate at Brien Holden Vision Institute, Sydney While a substantial...
May 1, 2024 By Dwight Akerman, OD, MBA, FAAO, FBCLA, FIACLE The management of juvenile-onset myopia is a critical public health issue,...
April 15, 2024 By Dwight Akerman, OD, MBA, FAAO, FBCLA, FIACLE Topical low-concentration atropine eye drops to help slow the progression of...
December 1, 2023 By Dr. Melinda Toomey, BAppSc (Optom), MOptom, GradCertOcTher, MBA, PhD Managing myopia is a multifaceted process that requires a...
September 1, 2022 Is percentage treatment effect the most accurate way to express myopia control efficacy? Treatment effect has been expressed in...
April 1, 2022 By Geetha Sravani, PhD Candidate, Brien Holden Vision Institute Myopia prevalence is high in many Asian countries. To delay...